share_log
Moomoo 24/7 ·  Mar 12 08:13
NewAmsterdam Pharma Announced Dosing Of The First Patient And Initiation Of TANDEM Phase 3 Trial To Evaluate Obicetrapib And Ezetimibe FDC In Adult Patients With Heterozygous Familial Hypercholesterolemia And/Or Atherosclerotic Cardiovascular Disease
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment